Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Computational Biology | 10 | 2021 | 3558 | 1.290 |
Why?
|
Data Mining | 4 | 2020 | 562 | 1.100 |
Why?
|
Decision Support Systems, Clinical | 4 | 2022 | 1175 | 1.090 |
Why?
|
Systems Biology | 3 | 2017 | 481 | 0.980 |
Why?
|
Veterans | 4 | 2024 | 2663 | 0.950 |
Why?
|
Medical Informatics | 5 | 2024 | 743 | 0.930 |
Why?
|
Pattern Recognition, Automated | 3 | 2016 | 979 | 0.920 |
Why?
|
User-Computer Interface | 5 | 2016 | 1404 | 0.860 |
Why?
|
Candida albicans | 3 | 2021 | 377 | 0.840 |
Why?
|
Programming Languages | 2 | 2017 | 133 | 0.820 |
Why?
|
Models, Genetic | 3 | 2017 | 3447 | 0.770 |
Why?
|
Pyrazinamide | 1 | 2021 | 61 | 0.720 |
Why?
|
Berberine | 1 | 2020 | 26 | 0.710 |
Why?
|
Genomics | 10 | 2023 | 5924 | 0.710 |
Why?
|
Electronic Health Records | 11 | 2023 | 4862 | 0.700 |
Why?
|
Stomatitis | 2 | 2013 | 270 | 0.660 |
Why?
|
Data Display | 2 | 2021 | 174 | 0.620 |
Why?
|
Streptococcus | 1 | 2019 | 197 | 0.620 |
Why?
|
Models, Theoretical | 3 | 2017 | 3563 | 0.600 |
Why?
|
Databases, Genetic | 4 | 2017 | 1751 | 0.600 |
Why?
|
Gene Expression Regulation, Bacterial | 2 | 2019 | 1141 | 0.580 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2016 | 3794 | 0.570 |
Why?
|
Sequence Analysis, DNA | 2 | 2018 | 4772 | 0.540 |
Why?
|
Markov Chains | 2 | 2017 | 968 | 0.520 |
Why?
|
Semantics | 1 | 2019 | 609 | 0.500 |
Why?
|
Health Level Seven | 4 | 2023 | 35 | 0.500 |
Why?
|
Synthetic Biology | 2 | 2019 | 186 | 0.500 |
Why?
|
Cross Infection | 2 | 2015 | 1427 | 0.490 |
Why?
|
Software | 6 | 2022 | 4459 | 0.490 |
Why?
|
Sucking Behavior | 1 | 2015 | 27 | 0.480 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2019 | 592 | 0.470 |
Why?
|
Genes | 2 | 2010 | 1824 | 0.460 |
Why?
|
Nonlinear Dynamics | 1 | 2017 | 490 | 0.460 |
Why?
|
Artificial Intelligence | 5 | 2023 | 2657 | 0.450 |
Why?
|
Genome, Bacterial | 1 | 2019 | 797 | 0.440 |
Why?
|
Audiovisual Aids | 1 | 2014 | 98 | 0.440 |
Why?
|
Microarray Analysis | 3 | 2019 | 752 | 0.440 |
Why?
|
Algorithms | 7 | 2017 | 14061 | 0.430 |
Why?
|
Drug Resistance, Bacterial | 1 | 2021 | 1069 | 0.430 |
Why?
|
Saliva | 2 | 2015 | 851 | 0.410 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2017 | 689 | 0.410 |
Why?
|
Antitubercular Agents | 1 | 2021 | 1385 | 0.400 |
Why?
|
Computer Simulation | 3 | 2016 | 6252 | 0.400 |
Why?
|
Professional Practice | 1 | 2013 | 313 | 0.370 |
Why?
|
Drug Therapy, Computer-Assisted | 1 | 2013 | 198 | 0.370 |
Why?
|
Mycobacterium tuberculosis | 1 | 2021 | 1918 | 0.340 |
Why?
|
Models, Statistical | 3 | 2021 | 5088 | 0.330 |
Why?
|
Leukemia, Myeloid | 1 | 2013 | 696 | 0.330 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2538 | 0.320 |
Why?
|
Dipeptides | 1 | 2011 | 386 | 0.320 |
Why?
|
Computer Graphics | 2 | 2008 | 344 | 0.310 |
Why?
|
Leukocyte Count | 1 | 2012 | 1602 | 0.310 |
Why?
|
Thrombosis | 1 | 2022 | 2949 | 0.300 |
Why?
|
Medical Oncology | 2 | 2017 | 2339 | 0.300 |
Why?
|
Tuberculosis | 1 | 2021 | 2013 | 0.290 |
Why?
|
Behavior | 1 | 2011 | 535 | 0.290 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2013 | 698 | 0.290 |
Why?
|
Information Theory | 1 | 2008 | 49 | 0.290 |
Why?
|
Bayes Theorem | 4 | 2014 | 2354 | 0.290 |
Why?
|
Antifungal Agents | 3 | 2021 | 769 | 0.280 |
Why?
|
Point-of-Care Systems | 1 | 2016 | 1217 | 0.280 |
Why?
|
United States Department of Veterans Affairs | 2 | 2022 | 934 | 0.270 |
Why?
|
Phenotype | 3 | 2013 | 16706 | 0.270 |
Why?
|
Transplantation Conditioning | 1 | 2013 | 1635 | 0.260 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2017 | 16041 | 0.260 |
Why?
|
Alcoholism | 1 | 2017 | 1977 | 0.260 |
Why?
|
Bacterial Proteins | 1 | 2019 | 3837 | 0.250 |
Why?
|
Clostridium Infections | 1 | 2012 | 564 | 0.250 |
Why?
|
Disease | 1 | 2011 | 675 | 0.240 |
Why?
|
Proteomics | 3 | 2008 | 3910 | 0.240 |
Why?
|
Neoplasm Proteins | 1 | 2016 | 3593 | 0.230 |
Why?
|
Humans | 51 | 2024 | 765734 | 0.230 |
Why?
|
Terminology as Topic | 2 | 2020 | 1535 | 0.230 |
Why?
|
Genetic Engineering | 1 | 2010 | 933 | 0.220 |
Why?
|
Radiation Injuries | 1 | 2011 | 1181 | 0.220 |
Why?
|
Telemedicine | 1 | 2021 | 3105 | 0.220 |
Why?
|
Engineering | 1 | 2004 | 55 | 0.220 |
Why?
|
Proteins | 2 | 2010 | 5996 | 0.210 |
Why?
|
Hearing Aids | 1 | 2004 | 58 | 0.210 |
Why?
|
Genome | 3 | 2018 | 1752 | 0.210 |
Why?
|
Indenes | 1 | 2023 | 59 | 0.210 |
Why?
|
Feeding Behavior | 1 | 2015 | 3210 | 0.200 |
Why?
|
Acoustics | 1 | 2004 | 235 | 0.200 |
Why?
|
Tryptophan | 1 | 2024 | 483 | 0.200 |
Why?
|
Drug Discovery | 3 | 2021 | 1063 | 0.200 |
Why?
|
Cluster Analysis | 2 | 2021 | 2720 | 0.190 |
Why?
|
Multiple Myeloma | 2 | 2017 | 5195 | 0.190 |
Why?
|
Triglycerides | 2 | 2019 | 2441 | 0.190 |
Why?
|
Halogenation | 1 | 2020 | 47 | 0.180 |
Why?
|
Knowledge Bases | 1 | 2021 | 96 | 0.180 |
Why?
|
Siderophores | 1 | 2020 | 61 | 0.170 |
Why?
|
Fluconazole | 1 | 2020 | 154 | 0.170 |
Why?
|
Drug Resistance, Multiple | 1 | 2020 | 255 | 0.160 |
Why?
|
Robotics | 1 | 2006 | 808 | 0.160 |
Why?
|
Streptomyces | 1 | 2019 | 91 | 0.160 |
Why?
|
Neoplasms | 3 | 2019 | 22345 | 0.160 |
Why?
|
Quality of Life | 1 | 2021 | 13462 | 0.160 |
Why?
|
Gene Regulatory Networks | 2 | 2019 | 1747 | 0.160 |
Why?
|
Principal Component Analysis | 1 | 2002 | 951 | 0.160 |
Why?
|
Auditory Perception | 1 | 2004 | 587 | 0.160 |
Why?
|
Publications | 1 | 2021 | 195 | 0.160 |
Why?
|
International Classification of Diseases | 3 | 2013 | 933 | 0.160 |
Why?
|
Intracellular Space | 1 | 2019 | 198 | 0.150 |
Why?
|
Gene Transfer, Horizontal | 1 | 2019 | 148 | 0.150 |
Why?
|
Endodeoxyribonucleases | 1 | 2019 | 165 | 0.150 |
Why?
|
Itraconazole | 1 | 2018 | 42 | 0.150 |
Why?
|
Melatonin | 1 | 2023 | 674 | 0.150 |
Why?
|
Gene Expression Regulation | 2 | 2019 | 11888 | 0.150 |
Why?
|
Socioeconomic Factors | 2 | 2022 | 7835 | 0.150 |
Why?
|
Biomedical Research | 1 | 2013 | 3458 | 0.150 |
Why?
|
Lovastatin | 1 | 2018 | 114 | 0.150 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2013 | 5753 | 0.150 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2019 | 393 | 0.140 |
Why?
|
Hospitalization | 2 | 2024 | 10806 | 0.140 |
Why?
|
Time | 2 | 2023 | 550 | 0.140 |
Why?
|
Microbial Sensitivity Tests | 2 | 2021 | 1971 | 0.140 |
Why?
|
Neuroprotective Agents | 1 | 2023 | 959 | 0.140 |
Why?
|
Head and Neck Neoplasms | 1 | 2011 | 2918 | 0.140 |
Why?
|
Phylogeny | 2 | 2019 | 2836 | 0.140 |
Why?
|
Astrocytes | 1 | 2024 | 1345 | 0.130 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 11865 | 0.130 |
Why?
|
Intensive Care Units | 4 | 2024 | 3800 | 0.130 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2019 | 3651 | 0.130 |
Why?
|
Base Sequence | 3 | 2021 | 12402 | 0.130 |
Why?
|
Clindamycin | 1 | 2016 | 138 | 0.130 |
Why?
|
Demography | 1 | 2021 | 1641 | 0.130 |
Why?
|
Microglia | 1 | 2024 | 1371 | 0.120 |
Why?
|
Reproducibility of Results | 5 | 2018 | 20120 | 0.120 |
Why?
|
Virulence | 1 | 2019 | 1288 | 0.120 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2002 | 1456 | 0.120 |
Why?
|
Anesthesia, General | 1 | 2002 | 1172 | 0.120 |
Why?
|
Oncogenes | 1 | 2021 | 1232 | 0.120 |
Why?
|
Anti-Bacterial Agents | 4 | 2020 | 7477 | 0.120 |
Why?
|
Streptococcal Infections | 1 | 2019 | 617 | 0.120 |
Why?
|
Natural Language Processing | 1 | 2023 | 1198 | 0.120 |
Why?
|
Halitosis | 1 | 2014 | 13 | 0.120 |
Why?
|
Sample Size | 1 | 2017 | 843 | 0.110 |
Why?
|
DNA, Bacterial | 1 | 2019 | 1476 | 0.110 |
Why?
|
Clinical Coding | 1 | 2015 | 188 | 0.110 |
Why?
|
Protein Array Analysis | 2 | 2006 | 399 | 0.110 |
Why?
|
ROC Curve | 3 | 2024 | 3618 | 0.110 |
Why?
|
Workflow | 1 | 2018 | 861 | 0.110 |
Why?
|
Escherichia coli | 1 | 2006 | 4214 | 0.110 |
Why?
|
Biofilms | 1 | 2018 | 641 | 0.110 |
Why?
|
Quality Assurance, Health Care | 1 | 2023 | 2175 | 0.110 |
Why?
|
Oral Hygiene | 1 | 2014 | 132 | 0.110 |
Why?
|
Drug Eruptions | 1 | 2016 | 334 | 0.110 |
Why?
|
Postoperative Complications | 1 | 2015 | 15749 | 0.110 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 2036 | 0.100 |
Why?
|
Pseudomonas aeruginosa | 1 | 2020 | 1276 | 0.100 |
Why?
|
Therapeutics | 1 | 2013 | 113 | 0.100 |
Why?
|
Predictive Value of Tests | 3 | 2015 | 15390 | 0.100 |
Why?
|
Area Under Curve | 2 | 2014 | 1639 | 0.100 |
Why?
|
Bioengineering | 1 | 2012 | 97 | 0.090 |
Why?
|
Leukocytosis | 1 | 2012 | 248 | 0.090 |
Why?
|
Internet | 3 | 2015 | 3103 | 0.090 |
Why?
|
Vascular Diseases | 1 | 2019 | 1159 | 0.090 |
Why?
|
Lipid Metabolism | 1 | 2019 | 1892 | 0.090 |
Why?
|
Chromosome Mapping | 1 | 2019 | 4618 | 0.090 |
Why?
|
Host-Pathogen Interactions | 1 | 2019 | 1461 | 0.090 |
Why?
|
DNA, Neoplasm | 1 | 2016 | 1740 | 0.090 |
Why?
|
Databases, Factual | 3 | 2017 | 8062 | 0.090 |
Why?
|
Biotechnology | 1 | 2012 | 284 | 0.090 |
Why?
|
Brain Ischemia | 1 | 2023 | 3000 | 0.090 |
Why?
|
Odds Ratio | 1 | 2022 | 9647 | 0.090 |
Why?
|
Information Dissemination | 2 | 2015 | 1142 | 0.090 |
Why?
|
Critical Illness | 2 | 2013 | 2744 | 0.080 |
Why?
|
Iatrogenic Disease | 1 | 2013 | 553 | 0.080 |
Why?
|
Information Storage and Retrieval | 2 | 2013 | 832 | 0.080 |
Why?
|
WT1 Proteins | 1 | 2010 | 182 | 0.080 |
Why?
|
Nephrons | 1 | 2010 | 165 | 0.080 |
Why?
|
Delayed Diagnosis | 1 | 2012 | 452 | 0.080 |
Why?
|
Mouth Mucosa | 1 | 2011 | 432 | 0.080 |
Why?
|
Animals | 11 | 2024 | 168731 | 0.080 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2009 | 1056 | 0.080 |
Why?
|
Cooperative Behavior | 1 | 2015 | 1511 | 0.080 |
Why?
|
Multigene Family | 1 | 2011 | 1081 | 0.070 |
Why?
|
Gene Expression Profiling | 4 | 2019 | 9522 | 0.070 |
Why?
|
DNA | 2 | 2013 | 7200 | 0.070 |
Why?
|
Forecasting | 2 | 2014 | 2936 | 0.070 |
Why?
|
United States | 4 | 2024 | 72898 | 0.070 |
Why?
|
Genome-Wide Association Study | 3 | 2017 | 12800 | 0.070 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2012 | 723 | 0.070 |
Why?
|
Data Interpretation, Statistical | 1 | 2016 | 2685 | 0.070 |
Why?
|
Medical Records Systems, Computerized | 1 | 2012 | 1195 | 0.070 |
Why?
|
Electrophoresis, Agar Gel | 1 | 2006 | 204 | 0.070 |
Why?
|
Mice | 7 | 2023 | 81792 | 0.060 |
Why?
|
Body Fluids | 1 | 2008 | 321 | 0.060 |
Why?
|
Systems Integration | 1 | 2008 | 427 | 0.060 |
Why?
|
Risk Factors | 3 | 2022 | 74831 | 0.060 |
Why?
|
Vocabulary, Controlled | 1 | 2006 | 171 | 0.060 |
Why?
|
Mutation | 3 | 2021 | 30184 | 0.060 |
Why?
|
Reference Values | 1 | 2012 | 4909 | 0.060 |
Why?
|
Chemokines, CXC | 1 | 2007 | 416 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2024 | 5388 | 0.060 |
Why?
|
Recurrence | 1 | 2017 | 8498 | 0.060 |
Why?
|
Fluid Therapy | 1 | 2008 | 584 | 0.060 |
Why?
|
Lung Neoplasms | 2 | 2024 | 13448 | 0.060 |
Why?
|
Communication | 1 | 2018 | 3914 | 0.060 |
Why?
|
Neoplastic Stem Cells | 1 | 2012 | 1352 | 0.060 |
Why?
|
Amplifiers, Electronic | 1 | 2004 | 16 | 0.060 |
Why?
|
Models, Molecular | 2 | 2019 | 5381 | 0.060 |
Why?
|
Receptor, Melatonin, MT1 | 1 | 2023 | 31 | 0.050 |
Why?
|
Automation | 1 | 2006 | 585 | 0.050 |
Why?
|
Tissue Distribution | 1 | 2008 | 2266 | 0.050 |
Why?
|
Self-Help Devices | 1 | 2004 | 62 | 0.050 |
Why?
|
Signal Transduction | 4 | 2023 | 23589 | 0.050 |
Why?
|
Alzheimer Disease | 1 | 2024 | 8727 | 0.050 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2005 | 506 | 0.050 |
Why?
|
Peptides | 2 | 2021 | 4331 | 0.050 |
Why?
|
Pandemics | 1 | 2022 | 8703 | 0.050 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2017 | 5336 | 0.050 |
Why?
|
DNA-Binding Proteins | 1 | 2019 | 9594 | 0.050 |
Why?
|
Mass Spectrometry | 2 | 2007 | 2194 | 0.050 |
Why?
|
Azoles | 1 | 2021 | 23 | 0.050 |
Why?
|
Polymorphism, Genetic | 1 | 2012 | 4249 | 0.050 |
Why?
|
Stroke | 1 | 2023 | 9747 | 0.050 |
Why?
|
Blood Proteins | 1 | 2007 | 1188 | 0.050 |
Why?
|
Female | 10 | 2024 | 395961 | 0.040 |
Why?
|
Ceftazidime | 1 | 2020 | 57 | 0.040 |
Why?
|
Fetal Blood | 1 | 2007 | 1369 | 0.040 |
Why?
|
Aging | 1 | 2019 | 8730 | 0.040 |
Why?
|
Veterans Health | 1 | 2022 | 216 | 0.040 |
Why?
|
Transcription, Genetic | 2 | 2012 | 7599 | 0.040 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2023 | 485 | 0.040 |
Why?
|
Fetus | 1 | 2007 | 1878 | 0.040 |
Why?
|
Tachycardia | 1 | 2002 | 594 | 0.040 |
Why?
|
Transcription Factors | 1 | 2019 | 12123 | 0.040 |
Why?
|
Graft vs Host Disease | 1 | 2012 | 3078 | 0.040 |
Why?
|
Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2019 | 116 | 0.040 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2010 | 3606 | 0.040 |
Why?
|
Gene Expression | 2 | 2010 | 7584 | 0.040 |
Why?
|
Parabens | 1 | 2019 | 117 | 0.040 |
Why?
|
Limit of Detection | 1 | 2019 | 272 | 0.040 |
Why?
|
Ergosterol | 1 | 2018 | 19 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2017 | 65180 | 0.040 |
Why?
|
Allosteric Regulation | 1 | 2019 | 425 | 0.040 |
Why?
|
Pregnancy | 3 | 2010 | 30248 | 0.040 |
Why?
|
Stem Cells | 1 | 2010 | 3539 | 0.030 |
Why?
|
Molecular Sequence Data | 1 | 2009 | 17595 | 0.030 |
Why?
|
Myelodysplastic Syndromes | 1 | 2007 | 1403 | 0.030 |
Why?
|
Proteome | 1 | 2007 | 1897 | 0.030 |
Why?
|
Infant, Newborn | 2 | 2015 | 26332 | 0.030 |
Why?
|
Cohort Studies | 2 | 2024 | 41631 | 0.030 |
Why?
|
Biological Assay | 1 | 2019 | 627 | 0.030 |
Why?
|
Male | 8 | 2024 | 363585 | 0.030 |
Why?
|
Carbon | 1 | 2019 | 677 | 0.030 |
Why?
|
Equipment Design | 1 | 2004 | 3485 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2020 | 1332 | 0.030 |
Why?
|
Gene Expression Regulation, Fungal | 1 | 2018 | 496 | 0.030 |
Why?
|
Metabolic Networks and Pathways | 1 | 2019 | 798 | 0.030 |
Why?
|
Models, Biological | 2 | 2014 | 9441 | 0.030 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2019 | 751 | 0.030 |
Why?
|
Monitoring, Physiologic | 1 | 2002 | 1792 | 0.030 |
Why?
|
Kidney | 1 | 2010 | 7066 | 0.030 |
Why?
|
Sirolimus | 1 | 2021 | 1544 | 0.030 |
Why?
|
Sulfur Compounds | 1 | 2014 | 32 | 0.030 |
Why?
|
Fungal Proteins | 1 | 2018 | 900 | 0.030 |
Why?
|
Retrospective Studies | 1 | 2022 | 81457 | 0.030 |
Why?
|
Uric Acid | 1 | 2019 | 809 | 0.030 |
Why?
|
Sulfides | 1 | 2014 | 166 | 0.030 |
Why?
|
Volatile Organic Compounds | 1 | 2014 | 86 | 0.030 |
Why?
|
Dental Plaque | 1 | 2014 | 214 | 0.030 |
Why?
|
Metabolome | 1 | 2019 | 1005 | 0.030 |
Why?
|
RNA, Messenger | 1 | 2007 | 12769 | 0.030 |
Why?
|
Adult | 4 | 2024 | 222974 | 0.020 |
Why?
|
Italy | 1 | 2014 | 851 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2016 | 2229 | 0.020 |
Why?
|
Middle Aged | 3 | 2024 | 222903 | 0.020 |
Why?
|
Caenorhabditis elegans | 1 | 2020 | 1477 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2019 | 3605 | 0.020 |
Why?
|
Dental Care | 1 | 2014 | 286 | 0.020 |
Why?
|
Molecular Sequence Annotation | 1 | 2012 | 523 | 0.020 |
Why?
|
Gene Frequency | 1 | 2016 | 3623 | 0.020 |
Why?
|
Genome, Human | 1 | 2022 | 4446 | 0.020 |
Why?
|
Tissue Culture Techniques | 1 | 2010 | 286 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2019 | 4885 | 0.020 |
Why?
|
Genetic Testing | 1 | 2021 | 3592 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2023 | 14445 | 0.020 |
Why?
|
Decision Making, Computer-Assisted | 1 | 2008 | 147 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2012 | 1837 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2012 | 1865 | 0.020 |
Why?
|
Oligonucleotides, Antisense | 1 | 2010 | 462 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2010 | 856 | 0.020 |
Why?
|
Mice, SCID | 1 | 2012 | 2627 | 0.020 |
Why?
|
Research | 1 | 2015 | 1975 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2002 | 14637 | 0.020 |
Why?
|
Research Design | 1 | 2022 | 6207 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2010 | 1885 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2011 | 59459 | 0.020 |
Why?
|
Aged | 2 | 2024 | 171050 | 0.020 |
Why?
|
Vasoconstrictor Agents | 1 | 2008 | 654 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5368 | 0.010 |
Why?
|
Protein Binding | 1 | 2016 | 9299 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2010 | 1673 | 0.010 |
Why?
|
RNA Interference | 1 | 2012 | 2828 | 0.010 |
Why?
|
Risk Assessment | 1 | 2024 | 24279 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2012 | 2839 | 0.010 |
Why?
|
Pregnant Women | 1 | 2007 | 575 | 0.010 |
Why?
|
Leukemia | 1 | 2010 | 1522 | 0.010 |
Why?
|
Quantitative Trait Loci | 1 | 2010 | 2137 | 0.010 |
Why?
|
Genotype | 1 | 2016 | 13024 | 0.010 |
Why?
|
Lasers | 1 | 2005 | 951 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 4563 | 0.010 |
Why?
|
Sex Factors | 1 | 2014 | 10605 | 0.010 |
Why?
|
Pilot Projects | 1 | 2013 | 8732 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 40066 | 0.010 |
Why?
|
Brain | 1 | 2024 | 27178 | 0.010 |
Why?
|
Age Factors | 1 | 2014 | 18375 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2012 | 8603 | 0.010 |
Why?
|
Boston | 1 | 2008 | 9337 | 0.010 |
Why?
|
Genetic Variation | 1 | 2010 | 6607 | 0.010 |
Why?
|
Disease Progression | 1 | 2012 | 13614 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 18061 | 0.010 |
Why?
|
Apoptosis | 1 | 2010 | 9511 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2012 | 18289 | 0.010 |
Why?
|
Child | 1 | 2014 | 80499 | 0.000 |
Why?
|
Adolescent | 1 | 2014 | 88781 | 0.000 |
Why?
|